Investorideas.com newswire, news and commentary for leading sectors

Monday, May 02, 2016

Biotech News: Q BioMed Inc (OTCQB: $QBIO) News: Mannin Research to Participate at ARVO 2016 Meeting

Q BioMed Inc (OTCQB: $QBIO) News: Mannin Research to Participate at ARVO 2016 Meeting



NEW YORK - May 2, 2016 (Investorideas.com Newswire) Q BioMed Inc. (OTC: QBIO), a biotechnology acceleration company announces that its technology partner Mannin Research Inc. will be attending the Association for Research in Vision and Ophthalmology (ARVO), which takes place from May 1-5, 2016 in Seattle Washington. Mannin Research executives will be meeting with its vendors and research partners. The meeting provides organizations the opportunity to further explore business development goals and other collaborative opportunities for the MAN-01 program for treatment of glaucoma.

The ARVO annual meeting is the largest gathering of eye and vision researchers in the world. The annual meeting runs from May 1st to 5th at the Washing State Convention Center in Seattle, Washington, attracting over 11,000 attendees from more than 75 countries.

Mannin's CEO, Dr. George N. Nikopoulos stated: "We are very pleased to be attending the meeting. We are looking forward to engaging in meaningful research discussions and exploring possible collaboration opportunities with other innovative groups in attendance."

In October 2015 Q BioMed Inc entered into an agreement with Mannin Research to exclusively license, with an option to acquire, the platform technology assets of Mannin Research, the developer of a new class of vascular therapeutics. Mannin's primary focus is developing a first-in-class therapeutic eye-drop for glaucoma in adults and children, using a research platform designed to help develop new drugs for that indication and cystic kidney disease, among other diseases. Lead drug candidate MAN-01 is designed to treat abnormal vessels within the eye-thus treating glaucoma at its root causes.

We invite our shareholders and interested parties to subscribe to our email list and stay informed on our website at http://www.qbiomed.com and follow us on the social media feeds we use.


About Q BioMed Inc.
Q BioMed Inc. ”Q“ is a biomedical acceleration and development company. We are focused on acquiring companies and biomedical assets. Q is dedicated to providing these target companies and assets, strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need.

Forward-Looking Statements:
This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Contact:
Denis Corin
CEO
Q BioMed Inc.
1 888 357 2435 

Visit this Company: http://www.qbiomed.com

More info on QBIO at Investorideas.com: http://www.investorideas.com/CO/QBIO/

Sign up for the free investor news and stock alerts:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure: QBIO has retained investorideas.com for PR, media, news publication and social media effective February 5th for three months: two thousand five hundred per month.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:
http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.








Friday, April 29, 2016

REMINDER: Gopher Protocol Inc. (OTCQB: $GOPH) Management to Be Guests on Upcoming K-TALK Radio Show on April 30th, 2016

REMINDER: Gopher Protocol Inc. (OTCQB: $GOPH) Management to Be Guests on Upcoming K-TALK Radio Show on April 30th, 2016

Wilkinson Financial Radio Show Will Host Discussion on Gopher Protocol's Proprietary Guardian Patch Tracking Technology, Which Does Not Require Conventional Network or GPS for Tracking



SAN DIEGO, CA - April 29, 2016 (Investorideas.com Newswire) Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher" and the "Company"), a development-stage Company developing a real-time, heuristic based, mobile technology, announces to its shareholders and followers that the Company's management team will be featured guests on K-TALK Radio on April 30, 2016. In an in-depth segment to be aired from 10:00 a.m. to 12:00 p.m. (Mountain Time), Michael Murray, the Company's Chief Executive Officer, and Dr. Danny Rittman Ph.D., its Chief Technology Officer, will discuss Gopher Protocol's proprietary mobile tracking licensed technology.

K-TALK AM630 is the longest running talk radio station in the State of Utah and the third longest running talk radio station in the country. The Wilkinson Financial Radio Show shares stories and principles of entrepreneurship and business planning, with a goal of inspiring and educating listeners. (http://www.k-talk.com/)

The show will cover the history and background of the Company and its technology, the challenges to develop an innovative technology and bring it to market, and lastly, the potential future prospects for the Company.

As a component of the Company's licensed technology, the first product that is being developed by the Company is the Guardian Patch, an electronic circuit including a proprietary microchip technology that is within a sticky patch package. Guardian Patch can be affixed to any object, mobile or static, in order to track its location anywhere on earth. It does not require conventional network or GPS for tracking.

Dr. Danny Rittman Ph.D., Chief Technology Officer, said, "This show provides us with an opportunity to explain in great detail the unique features of Guardian Patch and how this sticky patch can be affixed to any object in order to track it anywhere. The fact that it can work with or without GPS makes it a game-changer."


About Gopher Protocol Inc.
Gopher Protocol Inc. ("Gopher" and the "Company") (OTCQB: GOPH) (http://gopherprotocol.com/) is Development-stage Company that is developing a real-time, heuristic based, mobile technology, per license agreement it holds. Upon development, the technology will consist of a smart microchip, mobile application software and supporting software that run on a server. The system contemplates the creation of a global network, worldwide. Gopher believes this will be the first system that is developed using a human, heuristic based analysis engine. Since the core of the system will be its advanced microchip that will be able to be installed any mobile device, worldwide, Gopher expects that this will result in an internal, private network between all mobile devices utilizing the device by providing mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional mobile features.


Consumer and product website for Guardian Patch: http://www.guardianpatch.com/.


Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

Contact:
Dr. Dan Rittman, CTO
Gopher Protocol Inc.
888-685-7336

Visit this company: http://gopherprotocol.com/

More info on GOPH at Investorideas.com Visit: http://www.investorideas.com/CO/GOPH/

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Sign up for free news alerts

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GOPH is a PR , social media and publishing client and compensates Investorideas.com ( three months effective April 4, 2016- three thousand five hundred per month )

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.






#Investorideas Updates Global #Stock Directories; Additions Include #Biotech & #LifeSciences Stocks

#Investorideas Updates Global #Stock Directories; Additions Include #Biotech & #LifeSciences Stocks

(OTC:ENVD), (OTC:IMUN), (OTC:MDIT), (OCT:NAOV), (OTC:RXMD) and (OTC:PRGB) Added

Point Roberts, WA, Delta BC – April 29, 2016 – Investorideas.com, a global news source and investor resource covering leading sectors announces this week’s additions to its global stock directories include biotech & life sciences stocks.

Companies added include: Endonovo Therapeutics, Inc. (OTC: ENDV), Immune Therapeutics, Inc. (OTC: IMUN), Medite Cancer Diagnostics, Inc. (OTC: MDIT), NanoVibronix Inc. (OTC: NAOV), Progressive Care, Inc. (OTC: RXMD) and Protea Biosciences Group, Inc. (OTC: PRGB).

The newly added companies were participants in the recent SeeThru Equity & Brewer Group 2ndAnnual Innovations and Investor Conference held this past February.


About Investorideas.com - Big Ideas for Global Investors
InvestorIdeas.com is a digital news source and investor resource covering leading sectors including biotech and life sciences.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com

800-665-0411

Thursday, April 28, 2016

SilverCrest (TSXV: $SIL.V) Announces Additional High Grade Underground Results At Las Chispas; Commencement of Surface Drilling Program


SilverCrest (TSXV: $SIL.V) Announces Additional High Grade Underground Results At Las Chispas; Commencement of Surface Drilling Program


Vancouver - April 28, 2016 (Investorideas.com Newswire) SilverCrest Metals Inc. (TSXV: $SIL.V) ("SilverCrest" or the "Company") is pleased to announce additional results from the underground channel sampling program and the commencement of a surface drilling program at its Las Chispas Project ("Las Chispas") located in Sonora, Mexico , as previously announced on March 2, 2016. Las Chispas is in a prolific mining area with nearby precious metal producers. Historical reports indicate the presence of 14 veins in the district of which only three (Las Chispas, William Tell and Babicanora) have been previously mined extensively in the early 1900s, but none of which appear to have been drilled.

N. Eric Fier, CPG, P.Eng, President & CEO stated, "We continue to systematically complete our planned underground rehabilitation program at Las Chispas to evaluate areas of known high grade silver-gold mineralization. To date, we have accessed two kilometres of the estimated six kilometres of underground workings. Our first detailed underground channel sampling, as reported below, indicates continuous high grade areas that are easily accessible for potential future mining. In late March, we also commenced a surface drilling program to test extensions of known mineralized veins for potential new discoveries. For the next three months, we will be focusing on continually accessing historical underground workings to assess further high grade continuous mineralization."



Underground Rehabilitation Update
In an effort to start confirming continuity of underground high grade potential at Las Chispas, 36 continuous channel samples were collected at intervals about every 2.1 metres across the width of the vein for approximately 75 metres. This location at the William Tell Vein is easily accessible. Based on historic information, this vein has an estimated 1 kilometre strike length, can be projected to a depth of 300 metres, and has an average width of 1.5 metres. Sample results averaged 1.1 metres of 2.4 gpt gold and 174.9 gpt silver, or 358.1 gpt silver equivalent* (uncut, undiluted) over a 75 metre strike length. The following table summarizes the 17 most significant results of the 36 samples collected;

William Tell Vein



*AgEq based on 75:1 Au:Ag

All assays were completed by ALS Chemex in Hermosillo, Mexico and North Vancouver, BC.
The initial geochemical signature at Las Chispas is Ag-Au-Sb-Ba-Mn-Ca indicating a low to intermediate sulphidation epithermal system. Initial geochemical test results suggest that the veins at Las Chispas may be similar to both nearby producing Santa Elena and Mercedes deposits.

Surface Drilling Update
Concurrent with the underground rehabilitation, a surface drilling program of approximately 3,000 metres commenced in late March. To date, six holes have been completed for a total of 1,500 metres. This initial drill program is designed to test known mineralization, extensions of mineralization and the potential for new discoveries. All holes have intersected quartz stockwork and veining that are currently being logged and sampled. Upon receipt of assays, the results will be announced and integrated with the underground information.

The Company has applied for a MIA (Environmental Impact Statement) for an underground drilling program of 2,000 metres to test potential near-surface resource areas and deeper extensional targets of below the historical workings. Minimal underground work is required to begin underground drilling. Depending on permitting, this program is expected to start in the second half of 2016. This permit also includes the extraction of a 100,000-tonne bulk sample for testing and processing off site.

The Qualified Person under National Instrument 43-101 Standards of Disclosure for Mineral Projects for this news release is N. Eric Fier , CPG, P.Eng, and President and CEO for SilverCrest, who has reviewed and approved its contents.

Read this release and view images at: http://www.investorideas.com/CO/SILV/news/2016/04281.asp

About SilverCrest Metals Inc. (TSXV: SIL.V; OTC: SVCMF)
SilverCrest Metals Inc. is a Canadian precious metals exploration company headquartered in Vancouver, BC , that is focused on new discoveries, value-added acquisitions and targeting production in Mexico's historic precious metal districts. The Company is led by a proven management team in all aspects of the precious metal mining sector, including the pioneering of a responsible "phased approach" business model taking projects from discovery, finance, on time and on budget construction, and production with subsequent increased value to shareholders.

FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation. Such forward‑looking statements concern the exploration, rehabilitation and drilling plans of the Las Chispas Project. Such forward‑looking statements or information are based on a number of assumptions, which may prove to be incorrect. Assumptions have been made regarding, among other things: the conditions in general economic and financial markets; availability of skilled labour; timing and amount of expenditures related to rehabilitation and drilling programs; and effects of regulation by governmental agencies. The actual results could differ materially from those anticipated in these forward-looking statements as a result of risk factors including: the timing and content of work programs; results of exploration activities; the interpretation of drilling results and other geological data; receipt, maintenance and security of permits and mineral property titles; environmental and other regulatory risks; project cost overruns or unanticipated costs and expenses; and general market and industry conditions. Forward-looking statements are based on the expectations and opinions of the Company's management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statements were made. The Company undertakes no obligation to update or revise any forward-looking statements included in this news release if these beliefs, estimates and opinions or other circumstances should change, except as otherwise required by applicable law.

N. Eric Fier , CPG, P.Eng
President & CEO
SilverCrest Metals Inc.

Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE SilverCrest Metals Inc.

Contact:
SilverCrest Metals Inc.
Fred Cooper, Investor Relations
Telephone: +1 (604) 694-1730
Fax: +1 (604) 694-1761
Toll Free: 1-866-691-1730 (Canada & USA)
570 Granville Street, Suite 501, Vancouver, British Columbia V6C 3P1


More info on QBIO at Investorideas.com: http://www.investorideas.com/CO/SILV/

Sign up for the free investor news and stock alerts:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.Disclosure: SilverCrest Metals is an annual publishing client of Investorideas.com, publishing news, video and social media.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Tech Q&A: CTO of Gopher Protocol (OTCQB: GOPH) Explains How the Guardian Patch Could Potentially Save Your Life

Tech Q&A: CTO of Gopher Protocol (OTCQB: GOPH) Explains How the Guardian Patch Could Potentially Save Your Life

New Mobile Tracking Tech Will Track and Protect Anything You Care About; With or Without GPS


PERRIS, California, Point Roberts WA, April 28, 2016 - Investorideas.com , a global news source covering tech stocks interviews Danny Rittman, CTO of  Gopher Protocol Inc. (OTCQB:GOPH) to learn about its licensed technology, the Guardian Patch, aiming to hit consumer markets in 2017.
   
The Guardian Patch, under development, is a unique location technology that works with or without GPS. It is a stick-on tracking device that protects and tracks everything from a phone to a loved- one or a pet. Danny shares its history, current status and how the Guardian Patch could potentially save your life in the future.



Q: Investorideas.com: Danny, for investors that have no previous knowledge of your company and technology can briefly you tell us the history of the Guardian Patch and how your company came to license this technology?

A: Danny Rittman, CTO – The Guardian Patch device was born as a derivative of our microchip technology called GopherInsight™. Gopher Protocol is developing under exclusive license granted by me, mobile, intelligent technology that connects mobile devices via its private, secured communication protocol in order to provide advanced features. The Guardian Patch is based on that technology. Each Guardian Patch device is connected to all others via its private, secured protocol. The device is affixed onto objects, mobile or static and once affixing, starts its operation as a tracking device.

The user installs the Guardian app in order to track the Guardian Patch via mapping feature. The Guardian Patch uses GPS coordinates when GPS services are available. In places where GPS services are not available, it automatically switches to its own proprietary based technology in order to obtain its geographical location and send it through its network. For the user these activities are transparent. The Guardian Patch geographical location is shown on Google/Yahoo/Bing map regardless which method is used.

One Guardian Patch can be registered on multiple apps via its ID. In this way, multiple users can view a location of an object(s).

The Guardian Patch also works as an Emergency beacon. Upon detaching, it start transmitting Emergency signal about its location to all apps that it is registered on.

The Guardian Patch is designed to function for one full year. Upon detaching and functioning as an Emergency beacon, the Patch will constantly transmit its location until exhausting its battery life same as aircraft’s black boxes system.


Q: Investorideas.com: Can you explain how the Guardian Patch tracking works?

A: Danny Rittman, CTO – The Guardian Patch uses GPS coordinates when GPS services are available. In places where GPS services are not available, it automatically switches to its own proprietary based technology to obtain its geographical location and sending it through its network. For the user these activities are transparent. All he/she sees is the moving dot of the object on Guardian mapping app. The system is based among other confidential features on a proprietary RF (Radio Frequency) technology and ultimately providing worldwide coverage. The main advantage of the system is the fact that it is conventional-network independent. It does not require conventional network like Wi-Fi, Bluetooth or others.


Q: Investorideas.com: And what about the pull- off emergency sticker in case of emergency?

A: Danny Rittman, CTO - The Guardian Patch also works as an Emergency beacon. Upon detaching, it starts transmitting Emergency signal about its location to all apps that it is registered on. Typically the Guardian Patch transmits its location every few minutes but in the Emergency beacon mode it will constantly transmit its geographical location until exhausting its power source, similar to aircraft’s black box. The system has reserved power source just for emergency beacon purposes in order to ensure constant Emergency transmission for about 2-3 weeks. It can save lives!


Q: Investorideas.com: Can you explain how the Guardian Patch works with or without GPS and how that is a game-changer?

A: Danny Rittman, CTO - The Guardian Patch detects when a GPS services exist and then acquire its geographical location. These coordinates are transmitted via its proprietary Radio technology to the user’s mobile app to be presented on Guardian mapping app. If GPS services are not available due to topological conditions, for example, caves, tunnels, closed locations, the system automatically switches to its proprietary radio system in order to calculate and provide its location. Our technology works in most obscure topographical locations like underwater, underground and even outer space.


Q: Investorideas.com: Can you tell us the current status and development and what is needed next to bring it to market?

A: Danny Rittman, CTO - The Guardian Patch is currently in the hardware and software implementation stage. In parallel we are working on the product’s logistics of packaging, mass production and distribution. We aim to release commercial full first generation by Easter of 2017.


Q: Investorideas.com: Is there anything out in the marketplace like the Guardian Patch?  What makes this truly unique?

A: Danny Rittman, CTO - The Guardian Patch is the first technology of its kind. There are GPS based vehicles and many, short range, Bluetooth based, tracking devices in the market today. The tracking devices which using GPS are limited and need to have “clear skies” above. They are also require complicate installation and costly. The short-range, Bluetooth based devices can provide short range (Few dozen feet) tracking only. The Guardian Patch is the first and the only device that is not GPS-dependent or Bluetooth and provides long range coverage. Its price is affordable and its size/shape make him perfect device to be used for many tracking applications. Users can use it to track vehicles, small or large valuables and virtually anything!

About Gopher Protocol Inc. Gopher Protocol Inc. (OTCQB: GOPH) (“Gopher” and the "Company") (http://gopherprotocol.com/) is a development-stage company developing a real-time, heuristic based, mobile technology, per license agreement it holds. Upon development, the technology will consist of a smart microchip, mobile application software and supporting software that run on a server.  The system contemplates the creation of a global network, worldwide. Gopher believes this will be the first system that is developed using a human, heuristic based analysis engine. Since the core of the system will be its advanced microchip that will be able to be installed any mobile device, worldwide, Gopher expects that this will result in an internal, private network between all mobile devices utilizing the device by providing mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional mobile features.

About Investorideas.com - Global news source covering leading sectors including technology.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Contact Investorideas.com 800 665 0411

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GOPH is a PR , social media and publishing client and compensates Investorideas.com ( three months effective April 4, 2016 - three thousand five hundred per month )More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.




Q BioMed Inc (OTCQB: $QBIO) CEO Pens Management Piece Featured in Life Science Leader

Q BioMed Inc (OTCQB: $QBIO) CEO Pens Management Piece Featured in Life Science Leader


NEW YORK - April 28, 2016 (Investorideas.com Newswire) Q BioMed Inc. (OTC: QBIO), a biotechnology acceleration company reports the Company's CEO was featured in an article he wrote on venture capital titled Accelerators Enter When VCs Fear To Tread:

Life Science Leader magazine is an essential business journal for life science executives who work for everything from emerging biotechs to Big Pharmas. Their content is designed to inform readers of industry best practices and motivate them to implement those practices in their businesses.

Each month, Life Science Leader features interviews with executives from the leading pharma and biotech companies, including Pfizer, Merck, Daiichi Sankyo, Genentech, Genzyme, Eli Lilly, and Janssen, as well as the FDA and more. This exclusive thought leadership provides an in-depth look into industry trends and hot topics that will impact the growth of the pharma and biopharma markets. As the market is continually growing and innovating, these insights provide readers with actionable information and strategies to implement when navigating the evolving clinical, manufacturing, entrepreneurial, and regulatory landscapes.

Corin explains how times have changed for start-up biotechnology companies, though, and the challenges have grown in magnitude. These days, the very same venture capital firms that would hand out a few dollars in the early stages now are idling their time, investing much bigger sums only after much more development has occurred.

In the article, Corin leverages his expertise at Q BioMed Inc., where he focuses on acquiring licenses to innovative biomedical assets in the private company space or academic setting.
"Our team at Q Bio are dedicated to providing those developers with the strategic resources, developmental support, and expansion capital to ensure they meet their potential, with the ultimate goal of enabling them to provide products to patients in need. Our mission is to license and acquire innovative life sciences assets and accelerate their product development timelines to commercialize their drug candidates and devices or bring them to the next level in terms of valuation inflection and the attention of the larger Pharma players or IPO them as stand-alone companies or just grow a revenue model organically", states Corin.

Excerpt from the article:
"Most venture funds, for example, have become increasingly impatient to harvest returns from their investments, many expecting an 'exit' within only 2-4 years. This trend has been adverse for many biomedical technologies, since they generally have a much longer gestation cycle than communications, electronics or information technologies. In addition, many biomedical technologies require regulatory approvals, which further increases development costs and lengthens the investment cycle."

The one thing that really has not changed is the amount of equity the venture capitalists want when they finally do invest. For those who are only interested in getting their idea into the marketplace, giving up 80 or 90% of their company may be acceptable. Jonas Salk refused to patent his polio vaccine because his focus was preventing that disease and not making billions for himself. Handing off the headaches of running a business to people who studied accounting and marketing rather than organic chemistry and electrical engineering may be the solution for many researchers.

To read the entire article, please follow this link

About Q BioMed Inc.
Q BioMed Inc. ”Q“ is a biomedical acceleration and development company. We are focused on acquiring companies and biomedical assets. Q is dedicated to providing these target companies and assets, strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need.


Forward-Looking Statements:
This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Contact:
Denis Corin
CEO
Q BioMed Inc.
1 888 357 2435 

Visit this Company: http://www.qbiomed.com

More info on QBIO at Investorideas.com: http://www.investorideas.com/CO/QBIO/

Sign up for the free investor news and stock alerts:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure: QBIO has retained investorideas.com for PR, media, news publication and social media effective February 5th for three months: two thousand five hundred per month.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:
http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.






InvestorIdeas.com Newswire